Brief: Nuvation Bio Reports Second Quarter 2022 Financial Results And Provides Business Update
Aug 4 (Reuters) - Nuvation Bio Inc NUVB.N :
* NUVATION BIO REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES
BUSINESS
UPDATE
* FINANCIAL POSITION PROVIDES CASH RUNWAY THROUGH 2028
* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $703.8 MILLION AS OF
JUNE
30, 2022
* QTRLY LOSS PER SHARE $0.16
* Q2 EARNINGS PER SHARE VIEW $-0.13 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw20PZtla
Further company coverage: NUVB.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nuvation Bio
See all newsBrief: Nuvation Bio To Expand Pivotal Phase 3 Sigma Study Of Safusidenib For Idh1-Mutant Glioma To Six European Countries
Brief: Nuvation Bio To Report Third Quarter 2026 Financial Results And Provide Business Update On November 4, 2026
U.S. RESEARCH ROUNDUP-Everpure, Marvell Technology, Okta
Nuvation Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Nuvation Bio Q2 revenue beats estimates on IBTROZI growth